Logo
x

Search

Subscribe Now

Nobelpharma

Insights+: The US FDA New Drug Approvals in March 2022

Insights+: The US FDA New Drug Approvals in March 2022

  • April 21, 2022
Nobelpharma’s Hyftor Receives the US FDA’s Approval for the Treatment of Facial Angiofibroma in Patients with TSC

Nobelpharma’s Hyftor Receives the US FDA’s Approval for the Treatment of Facial Angiofibroma in Patients with TSC

  • April 4, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.